"Whether it’s a migraine, headache, neurological disorder, traumatic brain injury, or concussion we are here to help you get better. Our neurologists believe that healing comes from a multidisciplinary approach and that is why our neurology clinic employees experts in all fields - include Alzheimer, stroke, and Parkinson. From preventative measure for migraines and headaches, concussion testing and concussion care, and treatments for general neurological disorders all our treatments are personalized to the individual. Call today (203-914-1900) to schedule your consultation and find out how we can help you heal yourself!"

During the past decade, New England Institute for Neurology and Headache conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 1 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New England Institute for Neurology and Headache" #1 sponsor was "AEON Biopharma, Inc." with 4 trials, followed by "H. Lundbeck A/S" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Currax Pharmaceuticals" with 1 trials sponsored and "ElectroCore INC" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New England Institute for Neurology and Headache" #1 collaborator was "PPD" with 4 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "New England Institute for Neurology and Headache" are "Migraine" (6 trials), "Alzheimer Disease" (2 trials), "Cervical Dystonia" (2 trials), "Acute Migraine With or Without Aura" (1 trials) and "Aura" (1 trials). Many other conditions were trialed in "New England Institute for Neurology and Headache" in a lesser frequency.

Most popular intervention types in "New England Institute for Neurology and Headache" are "Drug" (14 trials), "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "ABP-450" (4 trials), "Eptinezumab" (2 trials), ""Investigational"Auto-injector (sumatriptan succinate)" (1 trials) and "AMG334" (1 trials). Other intervention names were less common.

The vast majority of trials in "New England Institute for Neurology and Headache" are 15 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "New England Institute for Neurology and Headache". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in New England Institute for Neurology and Headache, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in New England Institute for Neurology and Headache, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".